|
|
|
|
|
|
|
|
|
|
|
|
|
[ARTICLE] 5
<TABLE>
<S> <C>
[PERIOD-TYPE] QTR-2
[FISCAL-YEAR-END] MAR-31-2001
[PERIOD-END] SEP-30-2000
[CASH] $ 2,249
[SECURITIES] 6,170
[RECEIVABLES] 8,874
[ALLOWANCES] (200)
[INVENTORY] 10,496
[CURRENT-ASSETS] $ 28,638<F1>
[PP&E] 32,147
[DEPRECIATION] (19,813)
[TOTAL-ASSETS] $ 43,080<F2>
[CURRENT-LIABILITIES] $ 7,680
[BONDS] 0
[COMMON] 57,411
[PREFERRED-MANDATORY] 0
[PREFERRED] 0
[OTHER-SE] (30,830)
[TOTAL-LIABILITY-AND-EQUITY] $ 43,080
[SALES] $ 16,112
[TOTAL-REVENUES] 16,112
[CGS] 10,725
[TOTAL-COSTS] 14,482<F3>
[OTHER-EXPENSES] 103<F4>
[LOSS-PROVISION] 0
[INTEREST-EXPENSE] $ 483
[INCOME-PRETAX] 1,250
[INCOME-TAX] 25
[INCOME-CONTINUING] 0
[DISCONTINUED] 0
[EXTRAORDINARY] 0
[CHANGES] 0
[NET-INCOME] 1,225
[EPS-BASIC] 0.11
[EPS-DILUTED] 0.10
<FN>
<F1>Includes - Other assets - $1,049K.
<F2>Includes - Restricted cash - $984K; Other long term assets - $1,124K.
<F3>Includes - Research and development - $900K; Selling, marketing,
and administrative - $2,857K;
<F4>Includes - Interest Income ($138);other expense $271K
</FN>
</TABLE>
|
|